The Food and Drug Administration (FDA) has expanded its approval of a ketamine-derived nasal spray, Spravato (esketamine), as a standalone therapy for adults with treatment-resistant depression.

The FDA’s latest approval of the nasal spray Spravato (esketamine) CIII marks a major shift in how major depressive disorder is managed, allowing people who have tried at least two oral ...

Antonin Verreault's second goal of the game, scored 2:09 into overtime, lifted the Rouyn-Noranda Huskies to a 6-5 come-from-behind win over the visiting Baie-Comeau Drakkar in Quebec Maritimes ...